Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
ACS Infectious Diseases|March 19, 2021
Repurposing Infectious Disease Hits as Anti-<i>Cryptosporidium</i> LeadsMatthew A Hulverson, Ryan Choi, Molly C McCloskey, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 24, 2019
Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird modelsMarc P Hübner, Emma Gunderson, Ian Vogel, et al.
Science Translational Medicine|October 1, 2020
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetaseSumiti Vinayak, Rajiv S Jumani, Peter Miller, et al.
Nature Communications|May 11, 2018
A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparumAlison Roth, Steven P Maher, Amy J Conway, et al.
Nature Communications|June 10, 2018
Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparumAlison Roth, Steven P Maher, Amy J Conway, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2013
KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitroAnne-Marie Zeeman, Sandra M van Amsterdam, Case W McNamara, et al.
Communications Biology|February 12, 2022
Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistanceSabine Ottilie, Madeline R Luth, Erich Hellemann, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Journal of Medicinal Chemistry|February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel WarheadN G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
Pageof 9